Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism

Neuroscience Letters

Volumn 338, Issue 2, 2003, Pages 99-102

  Seidel, Kay ^a   Hamza, May ^a,b   Ates, Mehmet ^a   Gühring, Hans ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b African Union Organization St Abbassia   (Egypt)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Calcitonin gene related peptide; Delta 9 tetrahydrocannabinol; Endocannabinoids; Flurbiprofen; Nociception; Prostaglandin E2; Rat; Spinal superperfusion

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; DRONABINOL; FLURBIPROFEN; KETONE DERIVATIVE; PALMITYL TRIFLUOROMETHYL KETONE; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ANALGESIA; ARACHIDONIC ACID METABOLISM; CONCENTRATION RESPONSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SPINAL CORD;

EID: 0037468296     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01366-6     Document Type: Review

References (15)

1. Andreeva L., Rang H.P. Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vitro. Br. J. Pharmacol. 108:1993;185-190.
2. Gatley S.J., Gifford A.N., Volkow N.D., Lan R., Makriyannis A. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur. J. Pharmacol. 307:1996;331-338.
3. Gühring H., Schuster J., Hamza M., Ates M., Kotalla C.E., Brune K. HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test. Eur. J. Pharmacol. 429:2001;127-134.
4. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43:1991;143-201.
5. Ito S., Okuda-Ashitaka E., Minami T. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci. Res. 41:2001;299-332.
6. Ma Q.P., Woolf C.J. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones. J. Physiol. 486:(Pt 3):1995;769-777.
7. Millan M.J. The induction of pain: an integrative review. Prog. Neurobiol. 57:1999;1-164.
8. Morton C.R., Hutchison W.D. Release of sensory neuropeptides in the spinal cord: studies with calcitonin gene-related peptide and galanin. Neuroscience. 31:1989;807-815.
9. Oku R., Satoh M., Fujii N., Otaka A., Yajima H., Takagi H. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 403:1987;350-354.
10. Pestonjamasp V.K., Burstein S.H. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. Biochim. Biophys. Acta. 1394:1998;249-260.
11. Richardson J.D., Aanonsen L., Hargreaves K.M. Antihyperalgesic effects of spinal cannabinoids. Eur. J. Pharmacol. 345:1998;145-153.
12. Southall M.D., Michael R.L., Vasko M.R. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain. 78:1998;39-48.
13. Treede R.D., Meyer R.A., Raja S.N., Campbell J.N. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog. Neurobiol. 38:1992;397-421.
14. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231:1971;232-235.
15. Yu L.-C., Hansson P., Lundeberg S., Lundeberg T. Effects of calcitonin gene-related peptide-(8-37) on withdrawal responses in rats with inflammation. Eur. J. Pharmacol. 347:1998;275-282.